Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients

Figure 1

Prognostic value of the preoperative HCT in patients with lung cancer. (a) All patients with low HCT (n = 269) and high HCT (n = 753) (P < 0.001). (b) Squamous cell lung carcinoma patients with low HCT (n = 92) and high HCT (n = 177) (P = 0.281). (c) Lung adenocarcinoma patients with low HCT (n = 131) and high HCT (n = 462) (P < 0.001). (d) Younger patients with low HCT (n = 135) and high HCT (n = 429) (P = 0.030). (e) Older patients with low HCT (n = 134), and high HCT (n = 324) (P < 0.001). (f) Male patients with low HCT (n = 181) and high HCT (n = 409) (P < 0.001). (g) Female patients with low HCT (n = 88) and high HCT (n = 344) (P = 0.066).

(a)

(b)

(c)

(d)

(e)

(f)

(g)